Effectiveness of a management program for outpatient clinic or remote titration of beta-blockers in CRT patients: The RESTORE study.
暂无分享,去创建一个
L. Calò | A. Rapacciuolo | C. Mauro | S. Valsecchi | A. Ruocco | P. Palmisano | A. D'onofrio | E. Ammendola | M. Accogli | M. Campari | V. Bianchi | G. Del Giorno | A. Martino | F. Maresca | A. D’Onofrio
[1] W. Alexander. American College of Cardiology. , 2018, P & T : a peer-reviewed journal for formulary management.
[2] C. Leclercq,et al. Avoiding non-responders to cardiac resynchronization therapy: a practical guide , 2016, European heart journal.
[3] A. Capucci,et al. Association between remote implantable cardioverter defibrillator monitoring and beta-blocker utilization: An analysis from the EFFECT study , 2016, Journal of telemedicine and telecare.
[4] J. Skinner,et al. Use of Guideline-Directed Medications for Heart Failure Before Cardioverter-Defibrillator Implantation. , 2016, Journal of the American College of Cardiology.
[5] A. Capucci,et al. Remote monitoring improves outcome after ICD implantation: the clinical efficacy in the management of heart failure (EFFECT) study. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[6] L. Calò,et al. Evaluation of Synergistic Effects of Resynchronization Therapy and a β‐Blocker Up‐titration Strategy Based on a Predefined Patient‐Management Program: The RESTORE Study , 2015, Clinical cardiology.
[7] P. Ponikowski,et al. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long‐Term Registry , 2013, European journal of heart failure.
[8] Lluís Mont,et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.
[9] Maurizio Marzegalli,et al. Remote Monitoring Reduces Healthcare Use and Improves Quality of Care in Heart Failure Patients With Implantable Defibrillators: The Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators (EVOLVO) Study , 2012, Circulation.
[10] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.
[11] A. Gavazzi,et al. CArdiac resynchronization in combination with beta blocker treatment in advanced chronic heart failure (CARIBE-HF): the results of the CARIBE-HF study. , 2011, Acta cardiologica.
[12] P. Heidenreich,et al. Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up: The ALTITUDE Survival Study , 2010, Circulation.
[13] C. O'connor,et al. Comparison of Medical Therapy Dosing in Outpatients Cared for in Cardiology Practices With Heart Failure and Reduced Ejection Fraction With and Without Device Therapy: Report From IMPROVE HF , 2010, Circulation. Heart failure.
[14] G. Fonarow,et al. Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices: Primary Results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) , 2010, Circulation.
[15] T. Burroughs,et al. Underutilization of β-Blockers in Patients Undergoing Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Procedures , 2010, Circulation. Cardiovascular quality and outcomes.
[16] A. de Silvestri,et al. A meta-analysis of remote monitoring of heart failure patients. , 2009, Journal of the American College of Cardiology.
[17] Harlan M Krumholz,et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Circulation.
[18] S. Najjar,et al. Rapid titration of carvedilol in patients with congestive heart failure: a randomized trial of automated telemedicine versus frequent outpatient clinic visits. , 2006, American heart journal.
[19] J. Conti,et al. Use of cardiac resynchronization therapy to optimize beta-blocker therapy in patients with heart failure and prolonged QRS duration. , 2005, The American journal of cardiology.
[20] J. Daubert,et al. Baseline characteristics of patients recruited into the CARE‐HF study , 2005, European journal of heart failure.
[21] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[22] Randall E. Williams,et al. Remote titration of carvedilol for heart failure patients by advanced practice nurses. , 2004, Journal of cardiac failure.
[23] D. DeMets,et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.
[24] B. Fagerberg,et al. How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). , 2003, Cardiac electrophysiology review.
[25] Paul A. Heidenreich,et al. Improving Guideline Adherence: A Randomized Trial Evaluating Strategies to Increase &bgr;-Blocker Use in Heart Failure , 2003, Circulation.
[26] J. Rouleau,et al. Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study. , 2003, JAMA.
[27] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .
[28] D. DeMets,et al. Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.
[29] CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.